Inhibition of interferon-γ signaling in oligodendroglia delays coronavirus clearance without altering demyelination

American Journal of Pathology

Volumn 168, Issue 3, 2006, Pages 796-804

  González, John M ^a   Bergmann, Cornelia C ^a   Ramakrishna, Chandran ^a   Hinton, David R ^a   Atkinson, Roscoe ^a   Hoskin, Jason ^a   Macklin, Wendy B ^b   Stohlman, Stephen A ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIVIRAL ACTIVITY; APOPTOSIS; ARTICLE; CENTRAL NERVOUS SYSTEM INFECTION; CONTROLLED STUDY; CORONAVIRUS; DEMYELINATION; ENCEPHALOMYELITIS; INFLAMMATORY CELL; MACROPHAGE; MOUSE; MURINE HEPATITIS CORONAVIRUS; MYELIN SHEATH; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE; VIRUS LOAD; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS STRAIN;

EID: 33644638650     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2006.050496     Document Type: Article

References (59)

1. Tyler KL, Gonzalez-Scarano F: Viral diseases of the central nervous system. Viral pathogenesis. Edited by N Nathanson. Philadelphia, Lippincott-Raven, 1996, pp 837-855
2. Griffin DE: Immune responses to RNA-virus infections of the CNS. Nat Rev Immunol 2003, 3:493-502
3. + T cells. Immunol Today 1990, 11:55-59
4. Kagi D, Vignaux F, Ledermann B, Burki K, Depraetere V, Nagata S, Hengartner H, Golstein P: Fas and perforin pathways as major mechanisms of T cell-mediated cytotoxicity. Science 1994, 265:528-530
5. Oldstone MB, Blount P, Southern PJ, Lampert PW: Cytoimmunotherapy for persistent virus infection reveals a unique clearance pattern from the central nervous system. Nature 1986, 321:239-243
6. + T cells, and interferons in persistent and acute infections of mice with lymphocytic choriomeningitis virus: implications for adoptive immunotherapy of virus carriers. Proc Natl Acad Sci USA 1997, 94:6874-6879
7. Marten NW, Stohlman SA, Bergmann CC: MHV infection of the CNS: mechanisms of immune-mediated control. Viral Immunol 2001, 14:1-18
8. Wang FI, Hinton DR, Gilmore W, Trousdale MD, Fleming JO: Sequential infection of glial cells by the murine hepatitis virus JHM strain (MHV-4) leads to a characteristic distribution of demyelination. Lab Invest 1992, 66:744-754
9. + T cells during viral persistence in the central nervous system. J Immunol 1999, 163:3379-3387
10. Bergmann CC, Parra B, Hinton DR, Ramakrishna C, Dowdell KC, Stohlman SA: Perforin and gamma interferon-mediated control of coronavirus central nervous system infection by CD8 T cells in the absence of CD4 T cells. J Virol 2004, 78:1739-1750
11. Ramakrishna C, Stohlman SA, Atkinson RD, Shlomchik MJ, Bergmann CC: Mechanisms of central nervous system viral persistence: the critical role of antibody and B cells. J Immunol 2002, 168:1204-1211
12. + T cells. J Immunol 1998, 160:2896-2904
13. Wu GF, Dandekar AA, Pewe L, Perlman S: CD4 and CDS T cells have redundant but not identical roles in virus-induced demyelination. J Immunol 2000, 165:2278-2286
14. Liu MT, Chen BP, Oertel P, Buchmeier MJ, Armstrong D, Hamilton TA, Lane TE: The T cell chemoattractant IFN-inducible protein 10 is essential in host defense against viral-induced neurologic disease. J Immunol 2000, 165:2327-2330
15. Lin MT, Stohlman SA, Hinton DR: Mouse hepatitis virus is cleared from the central nervous systems of mice lacking perforin-mediated cytolysis. J Virol 1997, 71:383-391
16. Parra B, Hinton DR, Marten NW, Bergmann CC, Lin MT, Yang CS, Stohlman SA: IFN-gamma is required for viral clearance from central nervous system oligodendroglia. J Immunol 1999, 162:1641-1647
17. Richardson-Burns SM, Kleinschmidt-DeMasters BK, DeBiasi RL, Tyler KL: Progressive multifocal leukoencephalopathy and apoptosis of infected oligodendrocytes in the central nervous system of patients with and without AIDS. Arch Neurol 2002, 59:1930-1936
18. Barac-Latas V, Suchanek G, Breitschopf H, Stuehler A, Wege H, Lassmann H: Patterns of oligodendrocyte pathology in coronavirus-induced subacute demyelinating encephalomyelitis in the Lewis rat. Glia 1997, 19:1-12
19. Schobesberger M, Zurbriggen A, Doherr MG, Weissenbock H, Vandevelde M, Lassmann H, Griot C: Demyelination precedes oligodendrocyte loss in canine distemper virus-induced encephalitis. Acta Neuropathol (Berl) 2002, 103:11-19
20. Lampert PW, Sims JK, Kniazeff AJ: Mechanism of demyelination in JHM virus encephalomyelitis. Electron microscopic studies. Acta Neuropathol (Berl) 1973, 24:76-85
21. Wang FI, Stohlman SA, Fleming JO: Demyelination induced by murine hepatitis virus JHM strain (MHV-4) is immunologically mediated. J Neuroimmunol 1990, 30:31-41
22. Wu GF, Perlman S: Macrophage infiltration, but not apoptosis, is correlated with immune-mediated demyelination following murine infection with a neurotropic coronavirus. J Virol 1999, 73:8771-8780
23. Gonzalez JM, Bergmann CC, Fuss B, Hinton DR, Kangas C, Macklin WB, Stohlman SA: Expression of a dominant negative IFN-gamma receptor on mouse oligodendrocytes. Glia 2005, 51:22-34
24. Fleming JO, Trousdale MD, el-Zaatari FA, Stohlman SA, Weiner LP: Pathogenicity of antigenic variants of murine coronavirus JHM selected with monoclonal antibodies. J Virol 1986, 58:869-875
25. + T-cell epitopes within the surface glycoprotein of a neurotropic coronavirus and correlation with pathogenicity. J Virol 1995, 69:8127-8131
26. Tschen SI, Bergmann CC, Ramakrishna C, Morales S, Atkinson R, Stohlman SA: Recruitment kinetics and composition of antibody-secreting cells within the central nervous system following viral encephalomyelitis. J Immunol 2002, 168:2922-2929
27. Lin MT, Hinton DR, Marten NW, Bergmann CC, Stohlman SA: Antibody prevents virus reactivation within the central nervous system. J Immunol 1999, 162:7358-7368
28. Ramakrishna C, Bergmann CC, Atkinson R, Stohlman SA: Control of central nervous system viral persistence by neutralizing antibody. J Virol 2003, 77:4670-4678
29. + T cells within the central nervous system. J Virol 2000, 74:7903-7910
30. +-T-cell expansion and trafficking following central nervous system infection. J Virol 2003, 77:2775-2778
31. Dandekar AA, Wu GF, Pewe L, Perlman S: Axonal damage is T cell mediated and occurs concomitantly with demyelination in mice infected with a neurotropic coronavirus. J Virol 2001, 75:6115-6120
32. Bonetti B, Pohl J, Gao YL, Raine CS: Cell death during autoimmune demyelination: effector but not target cells are eliminated by apoptosis. J Immunol 1997, 159:5733-5741
33. Schwartz T, Fu L, Lavi E: Differential induction of apoptosis in demyelinating and nondemyelinating infection by mouse hepatitis virus. J Neurovirol 2002, 8:392-399
34. D'Souza SD, Bonetti B, Balasingam V, Cashman NR, Barker PA, Troutt AB, Raine CS, Antel JP: Multiple sclerosis: fas signaling in oligodendrocyte cell death. J Exp Med 1996, 184:2361-2370
35. Hisahara S, Yuan J, Momoi T, Okano H, Miura M: Caspase-11 mediates oligodendrocyte cell death and pathogenesis of autoimmune-mediated demyelination. J Exp Med 2001, 193:111-122
36. + cytotoxic T-lymphocyte clone. J Virol 1994, 68:7540-7545
37. + T cells in the central nervous system. J Immunol 2004, 173:6265-6273
38. Parra B, Lin MT, Stohlman SA, Bergmann CC, Atkinson R, Hinton DR: Contributions of Fas-Fas ligand interactions to the pathogenesis of mouse hepatitis virus in the central nervous system. J Virol 2000, 74:2447-2450
39. Ruijs TC, Freedman MS, Grenier YG, Olivier A, Antel JP: Human oligodendrocytes are susceptible to cytolysis by major histocompatibility complex class I-restricted lymphocytes. J Neuroimmunol 1990, 27:89-97
40. Scolding NJ, Jones J, Compston DA, Morgan BP: Oligodendrocyte susceptibility to injury by T-cell perforin. Immunology 1990, 70:6-10
41. Redwine JM, Buchmeier MJ, Evans CF: In vivo expression of major histocompatibility complex molecules on oligodendrocytes and neurons during viral infection. Am J Pathol 2001, 159:1219-1224
42. Kundig TM, Hengartner H, Zinkernagel RM: T cell-dependent IFN-gamma exerts an antiviral effect in the central nervous system but not in peripheral solid organs. J Immunol 1993, 150:2316-2321
43. Parra B, Hinton DR, Lin MT, Cua DJ, Stohlman SA: Kinetics of cytokine mRNA expression in the central nervous system following lethal and nonlethal coronavirus-induced acute encephalomyelitis. Virology 1997, 233:260-270
44. + T cells and viral spread to demyelinating disease. J Immunol 2000, 164:4080-4088
45. Zimprich F, Winter J, Wege H, Lassmann H: Coronavirus induced primary demyelination: indications for the involvement of a humoral immune response. Neuropathol Appl Neurobiol 1991, 17:469-484
46. Lipton HL, Gilden DH: Viral diseases of nervous system: persistent infections. Viral Pathogenesis. Edited by N Nathanson. Philadelphia, Lippincott-Raven, 1997, pp 855-869
47. Fazakerley JK: Pathogenesis of Semliki Forest virus encephalitis. J Neurovirol 2002, 8(Suppl 2):66-74
48. Martin R, McFarland HF, McFarlin DE: Immunological aspects of demyelinating diseases. Annu Rev Immunol 1992, 10:153-187
49. Rosenthal A, Fujinami RS, Lampert PW: Mechanism of Theiler's virus-induced demyelination in nude mice. Lab Invest 1986, 54:515-522
50. Botteron C, Zurbriggen A, Griot C, Vandevelde M: Canine distemper virus-immune complexes induce bystander degeneration of oligodendrocytes. Acta Neuropathol (Berl) 1992, 83:402-407
51. + T cells prevents lesions of demyelination in Semliki Forest virus infection. J Virol 1993, 67:7629-7633
52. Griot C, Burge T, Vandevelde M, Peterhans E: Antibody-induced generation of reactive oxygen radicals by brain macrophages in canine distemper encephalitis: a mechanism for bystander demyelination. Acta Neuropathol (Berl) 1989, 78:396-403
53. Houtman JJ, Fleming JO: Dissociation of demyelination and viral clearance in congenitally immunodeficient mice infected with murine coronavirus JHM. J Neurovirol 1996, 2:101-110
54. Barnett MH, Prineas JW: Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann Neurol 2004, 55:458-468
55. Sabelko KA, Kelly KA, Nahm MH, Cross AH, Russell JH: Fas and Fas ligand enhance the pathogenesis of experimental allergic encephalomyelitis, but are not essential for immune privilege in the central nervous system. J Immunol 1997, 159:3096-3099
56. An S, Chen CJ, Yu X, Leibowitz JL, Makino S: Induction of apoptosis in murine coronavirus-infected cultured cells and demonstration of E protein as an apoptosis inducer. J Virol 1999, 73:7853-7859
57. Rodriguez M, Pavelko KD, Njenga MK, Logan WC, Wettstein PJ: The balance between persistent virus infection and immune cells determines demyelination. J Immunol 1996, 157:5699-5709
58. Lane TE, Asensio VC, Yu N, Paoletti AD, Campbell IL, Buchmeier MJ: Dynamic regulation of alpha- and beta-chemokine expression in the central nervous system during mouse hepatitis virus-induced demyelinating disease. J Immunol 1998, 160:970-978
59. Zhou J, Marten NW, Bergmann CC, Macklin WB, Hinton DR, Stohlman SA: Expression of matrix metalloproteinases and their tissue inhibitor during viral encephalitis. J Virol 2005, 79:4764-4773